Pacira | PCRX - Current Assets


Pacira reported $562.75M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Astellas Pharma JPY 1.37T 75.51B Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
J&J USD 54.61B 113M Sep/2025
Ligand Pharmaceuticals USD 753.92M 400.98M Sep/2025
Novo Nordisk DKK 181.88B 19.18B Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025
Zoetis USD 6.58B 660M Sep/2025